Even as the major biotech indices creep toward new all-time highs, buysiders are hard-pressed to identify any major risks that could cause a downturn in the fourth quarter. At the same time, there are few...
Ribomic Inc. (Tokyo:4591) fell Y398 (17%) to Y1,902 in its first day of trading on the Tokyo Stock Exchange's Mothers. Last week, Ribomic raised Y2.8 billion ($25.7 million) through the sale of 1.2 million shares...
Ribomic Inc. (Tokyo:4591) raised Y2.8 billion ($25.7 million) through the sale of 1.2 million shares at Y2,300 in an IPO on the Tokyo Stock Exchange's Mothers. The price values the company at Y27.8 billion ($258.3...
Ribomic Inc. , Tokyo, Japan Business: Autoimmune, Chemistry, Supply/Service Date announced: 2014-09-08 Type: IPO To be raised: Up to Y2.8 billion ($26.2 million) Shares: 1.2 million Price: Y2,000-Y2,300 Underwriters: Daiwa Securities Group; SMBC Nikko Securities; Mizuho;...
Ribomic Inc. hopes to become 2014's first biotech IPO on the Tokyo Stock Exchange this month. Last week, Ribomic set the price range at ¥2,000-¥2,300 for its IPO on the exchange's Mothers. If the aptamer...
Ribomic Inc. (Tokyo, Japan) plans to sell 1.2 million shares at Y2,000-Y2,300 in its IPO on the Tokyo Stock Exchange's Mothers. At the Y2,150 midpoint Ribomic would raise Y2.6 billion ($24.5 million) and be valued...
Ribomic Inc. , Tokyo, Japan Business: Autoimmune, Chemistry, Supply/Service Date announced: 2014-08-20 Type: IPO To be raised: Y2.7 billion ($26.3 million) Shares: 1.2 million Price: Y2,240 Underwriter: Daiwa Securities Group Overallotment: 324,600 Note: Ribomic is seeking...
Ribomic Inc. (Tokyo, Japan) is planning to raise Y2.7 billion ($26.3 million) through the sale of 1.2 million shares on the Tokyo Stock Exchange's Mothers in an IPO underwritten by Daiwa Securities and six other...
Even as the major biotech indices creep toward new all-time highs, buysiders are hard-pressed to identify any major risks that could cause a downturn in the fourth quarter. At the same time, there are few...
Ribomic Inc. (Tokyo:4591) fell Y398 (17%) to Y1,902 in its first day of trading on the Tokyo Stock Exchange's Mothers. Last week, Ribomic raised Y2.8 billion ($25.7 million) through the sale of 1.2 million shares...
Ribomic Inc. (Tokyo:4591) raised Y2.8 billion ($25.7 million) through the sale of 1.2 million shares at Y2,300 in an IPO on the Tokyo Stock Exchange's Mothers. The price values the company at Y27.8 billion ($258.3...
Ribomic Inc. , Tokyo, Japan Business: Autoimmune, Chemistry, Supply/Service Date announced: 2014-09-08 Type: IPO To be raised: Up to Y2.8 billion ($26.2 million) Shares: 1.2 million Price: Y2,000-Y2,300 Underwriters: Daiwa Securities Group; SMBC Nikko Securities; Mizuho;...
Ribomic Inc. hopes to become 2014's first biotech IPO on the Tokyo Stock Exchange this month. Last week, Ribomic set the price range at ¥2,000-¥2,300 for its IPO on the exchange's Mothers. If the aptamer...
Ribomic Inc. (Tokyo, Japan) plans to sell 1.2 million shares at Y2,000-Y2,300 in its IPO on the Tokyo Stock Exchange's Mothers. At the Y2,150 midpoint Ribomic would raise Y2.6 billion ($24.5 million) and be valued...
Ribomic Inc. , Tokyo, Japan Business: Autoimmune, Chemistry, Supply/Service Date announced: 2014-08-20 Type: IPO To be raised: Y2.7 billion ($26.3 million) Shares: 1.2 million Price: Y2,240 Underwriter: Daiwa Securities Group Overallotment: 324,600 Note: Ribomic is seeking...
Ribomic Inc. (Tokyo, Japan) is planning to raise Y2.7 billion ($26.3 million) through the sale of 1.2 million shares on the Tokyo Stock Exchange's Mothers in an IPO underwritten by Daiwa Securities and six other...